VHCP Management as of March 31, 2016
Portfolio Holdings for VHCP Management
VHCP Management holds 23 positions in its portfolio as reported in the March 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Dbv Technologies (DBVTF) | 25.2 | $29M | 457k | 63.51 | |
| Heron Therapeutics (HRTX) | 18.1 | $21M | 1.1M | 18.99 | |
| Coherus Biosciences (CHRS) | 11.3 | $13M | 611k | 21.23 | |
| Lipocine | 7.5 | $8.6M | 850k | 10.15 | |
| Anacor Pharmaceuticals In | 6.5 | $7.5M | 141k | 53.45 | |
| Avalanche Biotechnologies In | 5.0 | $5.7M | 1.1M | 5.17 | |
| Flamel Technologies | 4.8 | $5.5M | 500k | 11.04 | |
| Zafgen | 3.5 | $4.0M | 602k | 6.68 | |
| Ocera Therapeutics | 2.0 | $2.3M | 797k | 2.94 | |
| Akari Therapeutics | 1.9 | $2.2M | 158k | 14.00 | |
| Axovant Sciences | 1.8 | $2.1M | 184k | 11.48 | |
| Alcobra | 1.6 | $1.8M | 485k | 3.79 | |
| Ascendis Pharma A S (ASND) | 1.4 | $1.7M | 90k | 18.56 | |
| ARCA biopharma | 1.4 | $1.6M | 462k | 3.47 | |
| BioCryst Pharmaceuticals (BCRX) | 1.4 | $1.6M | 563k | 2.83 | |
| Beigene (ONC) | 1.3 | $1.5M | 51k | 29.31 | |
| Cynapsus Therapeutics | 1.1 | $1.3M | 109k | 12.13 | |
| Edge Therapeutics | 1.1 | $1.2M | 135k | 9.15 | |
| Global Blood Therapeutics In | 1.0 | $1.2M | 73k | 15.87 | |
| Cytomx Therapeutics (CTMX) | 0.7 | $828k | 64k | 12.90 | |
| D Stemline Therapeutics | 0.6 | $631k | 135k | 4.66 | |
| Regenxbio Inc equity us cm (RGNX) | 0.5 | $567k | 53k | 10.80 | |
| Pronai Therapeutics | 0.3 | $378k | 56k | 6.74 |
